PAYO Q1 2026 Earnings EPS Surpasses Estimates by 3245 as Core Growth Momentum Continues NTRS Q1 2026 Earnings EPS Surges 143 Above Estimates Amid Solid Operating Performance DBRG Q1 2026 Earnings EPS Misses Estimates Amid Mixed Market Response JBIO Q1 2026 Earnings WiderthanExpected Loss Amid PreRevenue Stage Catalyst Pharmaceuticals Inc CPRX Q1 2026 Earnings EPS Beats Estimates by 75 Stock Edges Slightly Lower